Immunologic Research

, Volume 33, Issue 1, pp 83–101

Effects of flagellin on innate and adaptive immunity

  • Anna N. Honko
  • Steven B. Mizel
Article

Abstract

Flagella are locomotive organelles present on a wide range of bacteria and are important for the pathogenesis of many species. Cells of the innate immune system lack memory perse, but recognize conserved pathogen-associated molecular patterns (PAMPs) through a family of type I membrane receptors known as Toll-like receptors (TLRs). Flagellin, the major structural component of flagella, is a highly conserved protein recognized in hosts by TLR5. Signaling of flagellin via TLR5/TLR4 heteromeric complexes enhances the diversity of the response, likely by engaging MyD88-independent adaptors to activate the interferon pathway. Flagellin is a potent immune activator, stimulating diverse biologic effects that mediate both innate inflammatory responses as well as the development of adaptive immunity. Binding of flagellin to the extracellular domain of TLR5 rapidly induces a signal cascade that culminates in the production of proinflammatory mediators such as cytokines, chemokines, and costimulatory molecules. This review focuses on the mechanisms of action of flagellin and its effects on both innate and adaptive immunity.

Key Words

Flagellin Toll-like receptors TLR5 Innate immunity Adaptive immunity Adjuvant 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Iino T: Genetics of structure and function of bacterial flagella. Ann Rev Genetics 1977;11:161–182.Google Scholar
  2. 2.
    Macnab RM: How bacteria assemble flagella. Ann Rev Microbiology 2003;57:77–100.Google Scholar
  3. 3.
    Wei L, Joys T: Covalent structure of three phase-1 flagellar filament proteins of Salmonella. J Mol Biol 1985;186:791–803.PubMedGoogle Scholar
  4. 4.
    Joys TM: The covalent structure of the phase-1 flagellar filament protein of Salmonella typhimurium and its comparison with other flagellins. J Biol Chem 1985;260:15758–15761.PubMedGoogle Scholar
  5. 5.
    Yonekura K, Maki-Yonekura S, Namba K: Complete atomic model of the bacterial flagellar filament, by electron cryomicroscopy. Nature 2003;424:643–650.PubMedGoogle Scholar
  6. 6.
    Samatey FA, Imada K, Vonderviszt F, Shirakihara Y, Namba K: Crystallization of the F41 fragment of flagellin and data collection from extremely thin crystals. J Struct Biol 2000;132:106–111.PubMedGoogle Scholar
  7. 7.
    Samatey FA, Imada K, Nagashima S, et al: Structure of the bacterial flagellar protofilament and implications for a switch for supercoiling. Nature 2001;410:331–337.PubMedGoogle Scholar
  8. 8.
    Carsiotis M, Weinstein DL, Karch H, Holder IA, O'Brien AD: Flagella of Salmonella typhimurium are a virulence factor in infected C57BL/6J mice Infect Immun 1984;46:814–818.PubMedGoogle Scholar
  9. 9.
    Stecher B, Hapfelmeier S, Müller C, Kremer M, Stallmach T, Hardt WD: Flagella and chemotaxis are required for efficient induction of Salmonella enterica serovar Typhimurium colitis in streptomycin-pretreated mice. Infect Immun 2004;72:4138–4150.PubMedGoogle Scholar
  10. 10.
    Feldman M, Bryan R, Rajan S, et al: Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect Immun 1998;66:43–51.PubMedGoogle Scholar
  11. 11.
    Cobb LM, Mychaleckyj JC, Wozniak DJ, López-Boado YS: Pseudomonas aeruginosa flagellin and alginate elicit very distinct gene expression patterns in airway epithelial cells: implications for cystic fibrosis disease. J Immunol 2004;173:5659–5670.PubMedGoogle Scholar
  12. 12.
    Wolfgang MC, Jyot I, Goodman AL, Ramphal R, Lory S: Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients. Proc Natl Acad Sci USA 2004;101:6664–6668.PubMedGoogle Scholar
  13. 13.
    Mizel SB, Kucera LS, Richardson SH, Ciacci F, Iyer NP: Regulation of macrophage activation and human immunodeficiency virus production by imasive Salmonella strains. Infect Immun 1995;63:1820–1826.PubMedGoogle Scholar
  14. 14.
    Ciacci-Woolwine F, Kucera LS, Richardson SH, Iyer NP, Mizel SB: Salmonellae activate tumor necrosis factor alpha production in a human promonocytic cell line via a released polypeptide. Infect Immun 1997; 65:4624–4633.PubMedGoogle Scholar
  15. 15.
    Ciacci-Woolwine F Blomfield IC, Richardson SH, Mizel SB: Samonella flagellin induces tumor necrosis factor alpha in a human promonocytic cell line. Infect Immun 1998;66:1127–1134.PubMedGoogle Scholar
  16. 16.
    McDermott PF, Ciacci-Woolwine F, Snipes JA, Mizel SB: High-affinity interaction between Gram-negative flagellin and a cell surface polypeptide results in human monocyte activation. Infect Immun 2000;68:5525–5529.PubMedGoogle Scholar
  17. 17.
    Aderem A and Ulevitch RJ: Toll-like receptors in the induction of the innate immune response. Nature 2000;406:782–787.PubMedGoogle Scholar
  18. 18.
    Medzhitov R: Toll-like receptors and innate immunity. Nat Rev Immunol 2001;1:135–145.PubMedGoogle Scholar
  19. 19.
    Janssens S and Beyaert R: Role of Toll-like receptors in pathogen recognition. Clin Microbiol Rev 2003;16:637–646.PubMedGoogle Scholar
  20. 20.
    Medzhitov R, Preston-Hurlburt P, Janeway CA, Jr: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388:394–397.PubMedGoogle Scholar
  21. 21.
    Akira S, Takeda K, Kaisho T: Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001;2:675–680.PubMedGoogle Scholar
  22. 22.
    Mazzoni A and Segal DM: Controlling the Toll road to dendritic cell polarization. J Leukoc Biol 2004;75:721–730.PubMedGoogle Scholar
  23. 23.
    Zhang D, Zhang G, Hayden MS, et al.: A Toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004;303:1522–1526.PubMedGoogle Scholar
  24. 24.
    Kawai T, Takeuchi O, Fujita T, et al: Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 2001;167:5887–5894.PubMedGoogle Scholar
  25. 25.
    Toshchakov V, Jones BW, Perera P-Y, et al: TLR4, but not TLR2, mediates IFN-β-induced STAT1α/β-dependent gene expression in macrophages. Nat Immunol 2002;3:392–398.PubMedGoogle Scholar
  26. 26.
    Moors MA, Li L, Mizel SB: Activation of interleukin-1 receptor-associated kinase by Gram-negative flagellin. Infect Immun 2001;69:4424–4429.PubMedGoogle Scholar
  27. 27.
    Jin F, Nathan C, Radzioch D, Ding A: Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 1997;88:417–426.PubMedGoogle Scholar
  28. 28.
    Sebastiani G, Leveque G, Larivière L, et al: Cloning and characterization of the murine Toll-like receptor 5 (Tlr5) gene: sequence and mRNA expression studies in Salmonella-susceptible MOLF/Ei mice. Genomics 2000;64:230–240.PubMedGoogle Scholar
  29. 29.
    Hayashi F, Smith KD, Ozinsky A, et al: The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001;410:1099–1103.PubMedGoogle Scholar
  30. 30.
    Miyake K: Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2. Trends Microbiology 2004;12:186–192.Google Scholar
  31. 31.
    Eaves-Pyles TD, Wong HR, Odoms K, Pyles RB: Salmonella flagellin-dependent proinflammatory responses are localized to the conserved amino and carboxyl regions of the protein. J Immunol 2001;167:7009–7016.PubMedGoogle Scholar
  32. 32.
    Donnelly MA and Steiner TS: Two nonadjacent regions in enteroaggregative Escherichia coli flagellin are required for activation of Toll-like receptor 5. J Biol Chem 2002;277:40456–40461.PubMedGoogle Scholar
  33. 33.
    Murthy KGK, Deb A, Goonesekera S, Szabó C, Salzman AL: Identification of conserved domains in Salmonella muenchen flagellin that are essential for its ability to activate TLR5 and to induce an inflammatory response in vitro. J Biol Chem 2004;279:5667–5675.PubMedGoogle Scholar
  34. 34.
    Smith KD, Andersen-Nissen E, Hayashi F, et al: Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nature Immunology 2003;4:1247–1253.PubMedGoogle Scholar
  35. 35.
    Mizel SB, West AP, Hantgan RR: Identification of a sequence in human Toll-like receptor 5 required for the binding of Gram-negative flagellin. J Biol Chem 2003;278:23624–23629.PubMedGoogle Scholar
  36. 36.
    Bell JK, Mullen GED, Leifer CA, Mazzoni A, Davies DR, Segal DM: Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunology 2003;24:528–533.Google Scholar
  37. 37.
    Vasselon T, Detmers PA, Charron D, Haziot A: TLR2 recognizes a bacterial lipopeptide through direct binding. J Immunol 2004;173:7401–7405.PubMedGoogle Scholar
  38. 38.
    Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z: MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 1997;7:837–847.PubMedGoogle Scholar
  39. 39.
    Burns K, Martinon F, Esslinger C, et al: MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem 1998;273:12203–12209.PubMedGoogle Scholar
  40. 40.
    Medzhitov R, Preston-Hurlburt P, Kopp E, et al: MyD88 is an adapter protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 1998;2:253–258.PubMedGoogle Scholar
  41. 41.
    Mizel SB, Snipes JA: Gram-negative flagellin-induced self-tolerance is associated with a block in Interleukin-1 receptor-associated kinase release from Toll-like receptor 5. J Biol Chem 2002;277:22414–22420.PubMedGoogle Scholar
  42. 42.
    Gohda J, Matsumura T, Inoue J: Cutting Edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not Toll/IL-1 receptor domain-containing a daptor-inducing IFN-β (TRIF)-dependent pathway in TLR signaling. J Immunol 2004;173:2913–2917.PubMedGoogle Scholar
  43. 43.
    Gewirtz AT, Navas TA, Lyons S, Godowski PJ, Madara JL: Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 2001;167:1882–1885.PubMedGoogle Scholar
  44. 44.
    Matsumoto M, Funami K, Tanabe M, et al: Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol 2003;171:3154–3162.PubMedGoogle Scholar
  45. 45.
    Hornef MW, Normark BH, Vandewalle A, Normark S: Intracellular recognition of lipopolysaccharide by Toll-like receptor 4 in intestinal epithelial cells. J Exp Med 2003;198:1225–1235.PubMedGoogle Scholar
  46. 46.
    Latz E, Schoenemeyer A, Visintin A, et al: TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004;5:190–198.PubMedGoogle Scholar
  47. 47.
    Underhill DM, Ozinsky A, Hajjar AM, et al: The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999; 401:811–815.PubMedGoogle Scholar
  48. 48.
    West AP, Dancho BA, Mizel SB: Gangliosides inhibit flagellin signaling in the absence of an effect on flagellin binding to Toll-like receptor 5. J Biol Chem 2005;280:9482–9488.PubMedGoogle Scholar
  49. 49.
    Dobrovolskaia MA, Vogel SN: Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes and Infection 2002;4:903–914.PubMedGoogle Scholar
  50. 50.
    Ogushi K, Wada A, Niidome T, et al: Gangliosides act as co-receptors for Salmonella enteritidis FliC and promote FliC induction of humanβ-defensin-2 expression in Caco-2 cells. J Biol Chem 2004;279:12213–12219.PubMedGoogle Scholar
  51. 51.
    Miljan EA, Bremer EG: Regulation of growth factor receptors by gangliosides. Sci STKE 2002;2002:1–10.Google Scholar
  52. 52.
    Ozinsky A, Underhill DM, Fontenot JD, et al: The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Natl Acad Sci USA 2000;97:13766–13771.PubMedGoogle Scholar
  53. 53.
    Mizel SB, Honko AN, Moors MA, Smith PS, West AP: Induction of macrophage nitric oxide production by Gram-negative flagellin involves signaling via heteromeric Toll-like receptor 5/Toll-like receptor 4 complexes. J Immunol 2003;170:6217–6223.PubMedGoogle Scholar
  54. 54.
    Gao JJ, Filla MB, Fultz MJ, Vogel SN, Russell SW, Murphy WJ: Autocrine/paracrine IFN-αβ mediates the lipopolysaccharide-induced activation of transcription factor Stat1 α in mouse macrophages: Pivotal role of Statlα in induction of the inducible nitric oxide synthase gene. J Immunol 1998;161:4803–4810.PubMedGoogle Scholar
  55. 55.
    Rosenbaum JT, Hartiala KT, Howes EL, Goldstein IM: Endotoxin tolerance diminishes certain antiinflammatory effects of endotoxin. Inflammation 1985;9:297–308.PubMedGoogle Scholar
  56. 56.
    Kobayashi KS, Flavell RA: Shielding the double0edged sword: negative regulation of the innate immune system. J Leukoc Biol 2004;75:428–433.PubMedGoogle Scholar
  57. 57.
    Poltorak A, He X, Smirnova I, et al: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085–2088.PubMedGoogle Scholar
  58. 58.
    Li L, Cousart S, Hu J, McCall CE: Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells. J Biol Chem 2000;275:23340–23345.PubMedGoogle Scholar
  59. 59.
    Jacinto R, Hartung T, McCall C, Li L: Lipopolysaccharide-and lipoteichoic acid-induced tolerance and cross-tolerance: Distinct alterations in IL-1 receptor-associated kinase. J Immunol 2002;168:6136–6141.PubMedGoogle Scholar
  60. 60.
    Medvedev AE, Lentschat A, Wahl LM, Golenbock DT, Vogel SN: Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J Immunol 2002;169:5209–5216.PubMedGoogle Scholar
  61. 61.
    Kobayashi K, Hernandez LD, Galán JE, Janeway CA, Jr, Medzhitov R, Flavell RA: IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002; 110:191–202.PubMedGoogle Scholar
  62. 62.
    Medvedev AE, Kopydlowski KM, Vogel SN: Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and Toll-like receptor 2 and 4 gene expression. J Immunol 2000;164:5564–5574.PubMedGoogle Scholar
  63. 63.
    Cao Z, Henzel WJ, Gao X: IRAK: a kinase associated with the interleukin-1 receptor. Science 1996;271:1128–1131.PubMedGoogle Scholar
  64. 64.
    Muzio M, Ni J, Feng P, Dixit VM: IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 1997;278:1612–1615.PubMedGoogle Scholar
  65. 65.
    Martin MU, Wesche H: Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Bioch Biophy Acta 2002;1592:265–280.Google Scholar
  66. 66.
    Vogel SN, Fitzgerald KA, Fenton MJ: TLRs: differential adapter utilization by Toll-like receptors mediates TLR-specific patterns of gene expression. Mol Interv 2003;3:466–477.PubMedGoogle Scholar
  67. 67.
    Kulka M, Alexopoulou L, Flavell RA, Metcalfe DD: Activation of mast cells by double-stranded RNA: Evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol 2004;114:174–182.PubMedGoogle Scholar
  68. 68.
    McCurdy JD, Lin T-J, Marshall JS: Toll-like receptor 4-mediated activation of murine mast cells. J Leukoc Biol 2001;70:977–984.PubMedGoogle Scholar
  69. 69.
    Supajatura V, Ushio H, Nakao A, Okumura K, Ra C, Ogawa H: Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J Immunol 2001;167:2250–2256.PubMedGoogle Scholar
  70. 70.
    Applequist SE, Wallin RPA, Ljunggren H-G: Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. Int Immunol 2002;14:1065–1074.PubMedGoogle Scholar
  71. 71.
    Ikeda T, Funaba M: Altered function of murine mast cells in response to lipopolysaccharide and peptidoglycan. Immunology Lett 2003;88:21–26.Google Scholar
  72. 72.
    Matsushima H, Yamada N, Matsue H, Shimada S: TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J Immunol 2004;173:531–541.PubMedGoogle Scholar
  73. 73.
    Hornung V, Rothenfusser S, Britsch S, et al.: Quantitative expression of Toll-like receptor 1–10 mRNA in cellular Subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002;168:4531–4537.PubMedGoogle Scholar
  74. 74.
    Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J: Regulatory T cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003;197:403–411.PubMedGoogle Scholar
  75. 75.
    Gelman AE, Zhang J, Choi Y, Turka LA: Toll-like receptor ligands directly promote activated CD4 T cell survival. J Immunol 2004;172:6065–6073.PubMedGoogle Scholar
  76. 76.
    Bourke E, Bosisio D, Golay J, Polentarutti N, Mantovani A: The toll-like receptor reperticite of human B lymphocytes: Inducible and selective expression of TLR9 and TLR10 in normal and transfored cells. Blood 2003;102:956–963.PubMedGoogle Scholar
  77. 77.
    Didierlaurent A, Ferrero I, Otten LA, et al.: Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response. J Immunol 2004;172:6922–6930.PubMedGoogle Scholar
  78. 78.
    Means TK, Hayashi F, Smith KD, Aderem A, Luster AD: The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells. J Immunol 2003;170:5165–5175.PubMedGoogle Scholar
  79. 79.
    Agrawal S, Agrawal A, Doughty B, et al.: Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol 2003;171:4984–4989.PubMedGoogle Scholar
  80. 80.
    Re F, Strominger JL: IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J Immunol 2004;173:7548–7555.PubMedGoogle Scholar
  81. 81.
    Liu T, Matsuguchi T, Tsuboi N, Yajima T, Yoshikai Y: Differences in expression of Toll-like receptors and their reactivities in dendritic cells in BALB/c and C57BL/6 mice. Infect Immun 2002;70:6638–6645.PubMedGoogle Scholar
  82. 82.
    Edwards AD, Diebold SS, Slack EMC, et al.: Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8α+ DC correlates with unresponsiveness to imidazoquinolines. Eur J Immunol 2003;33:827–833.PubMedGoogle Scholar
  83. 83.
    Datta SK, Redecke V, Prilliman KR, et al.: A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells. J Immunol 2003;170:4102–4110.PubMedGoogle Scholar
  84. 84.
    McSorley SJ, Ehst BD, Yu Y, Gewirtz AT: Bacterial flagellin is an effective adjuvant for CD4 T cells in vivo. J Immunol 2002;169:3914–3919.PubMedGoogle Scholar
  85. 85.
    Ciacci-Woolwine F, McDermott PF, Mizel SB: Induction of cytokine synthesis by flagella from Gram-negative bacteria may be dependent on the activation or differentiation state of human monocytes. Infect Immun 1999;67:5176–5185.PubMedGoogle Scholar
  86. 86.
    Eaves-Pyles T, Murthy K, Liaudet L, et al.: Flagellin, a novel mediator of Salmonella-induced epithelial activation and systemic inflammation: IκBα degradation, induction of nitric oxide synthase, induction of proin-flammatory mediators, and cardiovascular dysfunction. J Immunol 2001;166:1248–1260.PubMedGoogle Scholar
  87. 87.
    Liaudet L, Murthy KGK, Mabley JG, et al.: Comparison of inflammation, organ damage, and oxidant stress induced by Salmonella enterica serovar Muenchen flagellin and serovar Enteritidis lipopolysaccharide. Infect Immun 2002;70:192–198.PubMedGoogle Scholar
  88. 88.
    Liaudet L, Szabó C, Evgenov OV, et al.: Flagellin from Gram-negative bacteria is a potent mediator of acute pulmonary inflammation in sepsis. Shock 2003;19:131–137.PubMedGoogle Scholar
  89. 89.
    Honko AN, Mizel SB: Mucosal administration of flagellin induces innate immunity in the mouse lung. Infect Immun 2004;72:6676–6679.PubMedGoogle Scholar
  90. 90.
    Wu JY, Newton S, Judd A, Stocker B, Robinson WS: Expression of immunogenic epitopes of hepatitis B surface antigen with hybrid flagellin proteins by a vaccine strain of Salmonella. Proc Natl Acad Sci USA 1989;86:4726–4730.PubMedGoogle Scholar
  91. 91.
    Newton SM, Kotb M, Poirier T, Stocker BAD, Beachly EH: Expression and immunogenicity of a streptococcal M protein epitope inserted in Salmonella flagellin. Infect Immun 1991;59:2158–2165.PubMedGoogle Scholar
  92. 92.
    Newton SMC, Joys TM, Anderson SA, Kennedy RC, Hovi ME, Stocker BAD: Expression and immunogenicity of an 18-residue epitope of HIV 1 gp41 inserted in the flagellar protein of a Salmonella live vaccine. Res Microbiol 1995;146:203–216.PubMedGoogle Scholar
  93. 93.
    Cattozzo EM, Stocker BAD, Radaelli A, De Giuli Morghen C, Tognon M: Expression and immunogenicity of V3 loop epitopes of HIV-1, isolates SC and WMJ2, inserted in Salmonella flagellin. J Biotech 1997;56:191–203.Google Scholar
  94. 94.
    McEwen J, Levi R, Horwitz RJ, Arnon R: Synthetic recombinant vaccine expressing influenza haemagglutinin epitope in Salmonella flagellin leads to partial protection in mice. Vaccine 1992;10:405–411.PubMedGoogle Scholar
  95. 95.
    Verma NK, Ziegler HK, Wilson M, et al.: Delivery of class I and class II MHC-restricted T-cell epitopes of listeriolysin of Listeria monocytogenes by attenuated Salmonella. Vaccine 1995;13:142–150.PubMedGoogle Scholar
  96. 96.
    Levi R, Arnon R: Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection. Vaccine 1996;14:85–92.PubMedGoogle Scholar
  97. 97.
    Ben-Yedidia T, Marcus H, Reisner Y, Arnon R: Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection. Int Immunol 1999;11:1043–1051.PubMedGoogle Scholar
  98. 98.
    Jeon SH, Ben-Yedidia T, Arnon R: Intranasal immunization with synthetic recombinant vaccine containing multiple epitopes of influenza virus. Vaccine 2002;20:2772–2780.PubMedGoogle Scholar
  99. 99.
    Ben-Yedidia T, Arnon R: Effect of pre-existing carrier immunity on the efficacy of synthetic influenza vaccine. Immunology Lett 1998;64:9–15.Google Scholar
  100. 100.
    Ben-Yedidia T, Tarrab-Hazdai R, Schechtman D, Arnon R: Intranasal administration of synthetic recombinant peptide-based vaccine protects mice from infection by Schistosoma mansoni. Infect Immun 1999;67:4360–4366.PubMedGoogle Scholar
  101. 101.
    Cuadros C, Lopez-Hernandez FJ, Dominguez AL, McClelland M, Lustgarten J: Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses. Infect Immun 2004;72:2810–2816.PubMedGoogle Scholar
  102. 102.
    Hawn TR, Verbon A, Lettinga KD, et al: A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J Exp Med 2003;198:1563–1572.PubMedGoogle Scholar
  103. 103.
    Le Bon A, Schiavoni G, D'Agostino G, Gresser I, Belardelli F, Tough DF: Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001;14:461–470.PubMedGoogle Scholar
  104. 104.
    Le Bon A, Tough DF: Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol 2002;14:432–436.PubMedGoogle Scholar
  105. 105.
    Santini SM, Di Pucchio T, Lapenta C, Parlato S, Legozzi M, Belardelli F: A new type I IFN-mediated pathway for the rapid differentiation of monocytes into highly active dendritic cells. Stem Cells 2003;21:357–362.PubMedGoogle Scholar
  106. 106.
    Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K: Lipopolysaccharide-enhanced, Toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002;196:1645–1651.PubMedGoogle Scholar
  107. 107.
    Dodge IL, Carr MW, Cernadas M, Brenner MB: IL-6 production by pulmonary dendritic cells impedes Th1 immune responses. J Immunol 2003;170:4457–4464.PubMedGoogle Scholar
  108. 108.
    Mempel M, Voelcker V, Köllisch G, et al.: Toll-like receptor expression in human keratinocytes: nuclear factor κB controlled gene activation by Staphylococcus aureus is Toll-like receptor 2 but not Toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Derm 2003;121:1389–1396.PubMedGoogle Scholar
  109. 109.
    Baker BS, Ovigne J-M, Powles AV, Corcoran S, Fry L: Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis. Br J Derm 2003;148:670–679.Google Scholar
  110. 110.
    Sha Q, Truong-Tran AQ, Plitt JR, Beck LA, Schleimer RP: Activation of airway epithelial cells by Toll-like receptor agonists. Am J Respir Cell Mol Biol 2004;31:358–364.PubMedGoogle Scholar
  111. 111.
    Zhang J, Xu K, Ambati B, Yu F-S: Toll-like receptor 5-mediated corneal epithelial inflammatory responses to Pseudomonas aeruginosa flagellin. Invest Ophthalmol Vis Sci 2003;44:4247–4254.PubMedGoogle Scholar
  112. 112.
    Smith MF, Jr., Mitchell A, Li G, et al.: Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-κB activation and chemokine expression by epithelial cells. J Biol Chem 2003;278:32552–32560.PubMedGoogle Scholar
  113. 113.
    Torok AM, Bouton AH, Goldberg JB: Helicobacter pylori induces interleukin-8 secretion by Toll-like receptor 2- and Toll-like receptor 5-dependent and-independent pathways. Infect Immun 2005;73:1523–1531.PubMedGoogle Scholar
  114. 114.
    Schaefer TM, Desouza K, Fahey JV, Beagley KW, Wira CR: Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology 2004;112:428–436.PubMedGoogle Scholar
  115. 115.
    Lee SK, Stack A, Katzowitsch E, Aizawa SI, Suerbaum S, Josenhans C: Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5. Microbes Infection 2003;5:1345–1356.Google Scholar
  116. 116.
    Gewirtz AT, Yu Y, Krishna US, Israel DA, Lyons SL, Peek RM: Helicobacter pylori flagellin evades Toll-like receptor 5-mediated innate immunity. J Infect Diseases 2004;189:1914–1920.Google Scholar
  117. 117.
    Maaser C, Heidemann J, von Eiff C, et al: Human intestinal microvascular endothelial cells express Toll-like receptor 5: a binding partner for bacterial flagellin. J Immunol 2004;172:5056–5062.PubMedGoogle Scholar
  118. 118.
    Sierro F, Dubois B, Coste A, Kaiserlian D, Kraehenbuhl J-P, Sirard J-C: Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc Natl Acad Sci USA 2001;98:13722–13727.PubMedGoogle Scholar
  119. 119.
    Gewirtz AT, Simon PO, Jr, Schmitt CK, et al: Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response. J Clin Invest 2001;107:99–109.PubMedGoogle Scholar
  120. 120.
    Rhee SH, Keates AC, Moyer MP, Pothoulakis C: MEK is a key modulator for TLR5-induced interleukin-8 and MIP3α gene expression in non-transformed human colonic epithelial cells. J Biol Chem 2004;279:25179–25188.PubMedGoogle Scholar
  121. 121.
    Muzio M, Bosisio D, Polentarutti N, et al: Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 2000;164:5998–6004.PubMedGoogle Scholar
  122. 122.
    Tsuda Y, Takahashi H, Kobayashi M, Hanafusa T, Herndon DN, Suzuki F: Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity 2004;21:215–226.PubMedGoogle Scholar
  123. 123.
    Chalifour A, Jeannin P, Gauchat J-F, et al: Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers α-defensin production. Blood 2004;104:1778–1783.PubMedGoogle Scholar
  124. 124.
    Visintin A, Mazzoni A, Spitzer JH, Wyllie DH, Dower SK, Segal DM: Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol 2001;166:249–255.PubMedGoogle Scholar
  125. 125.
    Farina C, Theil D, Semlinger B, Hohlfeld R, Meinl E: Distinct responses of monocytes to Toll-like receptor ligands and inflammatory cytokines. Int Immunol 2004;16:799–809.PubMedGoogle Scholar
  126. 126.
    Oshikawa K, Sugiyama Y: Gene expression of Toll-like receptors and associated molecules induced by inflammatory stimuli in the primary alveolar macrophage. Biochem Biophy Res Commun 2003;305:649–655.Google Scholar
  127. 127.
    Sodhi A, Sharma RK, Batra HV, Tuteja U: Recombinant fraction 1 protein of Yersinia pestis activates murine peritoneal macrophages in vitro. Cell Immunol 2004;229:52–61.PubMedGoogle Scholar
  128. 128.
    Peiser M, Wanner R, Kolde G: Human epidermal Langerhans cells differ from monocyte-derived Langerhans cells in CD80 expression and in secretion of IL-12 after CD40 cross-linking. J Leukoc Biol 2004;76:616–622.PubMedGoogle Scholar
  129. 129.
    Bowman CC, Rasley A, Tranguch SL, Marriott I: Cultured astrocytes express Toll-like receptors for bacterial products. Glia 2003;43:281–291.PubMedGoogle Scholar
  130. 130.
    Madrazo DR, Tranguch SL, Marriott I: Signaling via Toll-like receptor 5 can initiate inflammatory mediator production by murine osteoblasts. Infect Immun 2003;71:5418–5421.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2005

Authors and Affiliations

  • Anna N. Honko
    • 1
  • Steven B. Mizel
    • 1
  1. 1.Department of Microbiology and ImmunologyWake Forest University School of Medicine Medical Center BoulevardWinston-Salem

Personalised recommendations